共 50 条
- [42] The use of extrapolation based on modeling and simulation to support high-dose regimens of ceftaroline fosamil in pediatric patients with complicated skin and soft-tissue infections CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2021, 10 (06): : 551 - 563
- [43] Population pharmacokinetic (PPK) analysis of ceftaroline (CPT) in patients with complicated skin and skin structure infection (cSSSI) or community-acquired pneumonia (CAP). PHARMACOTHERAPY, 2012, 32 (10): : E211 - E212
- [44] Ceftaroline fosamil treatment patterns and outcomes in adults with community-acquired pneumonia: a real-world multinational, retrospective study JAC-ANTIMICROBIAL RESISTANCE, 2024, 6 (03):
- [46] Population Pharmacokinetic Modeling and Probability of Target Attainment Analyses in Asian Patients With Community-Acquired Pneumonia Treated With Ceftaroline Fosamil CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2019, 8 (05): : 682 - 694
- [48] Real-World Use and Treatment Outcomes of Ceftaroline Fosamil in Patients with Complicated Skin and Soft Tissue Infection: A Multinational Retrospective Study INFECTION AND DRUG RESISTANCE, 2024, 17 : 2773 - 2783
- [49] Spectrum and potency of ceftaroline against leading pathogens causing community-acquired respiratory tract and skin and soft tissue infections in Latin America, 2010 BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2013, 17 (05): : 564 - 572